<DOC>
	<DOCNO>NCT00191841</DOCNO>
	<brief_summary>To evaluate clinical response rate neoadjuvant chemotherapy gemcitabine cisplatin patient operable NSCLC</brief_summary>
	<brief_title>Gemcitabine Combination With Cisplatin Neoadjuvant NSCLC Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologic cytologic diagnosis operable nonsmall cell lung cancer ( IBIIIA ) prior chemotherapy WHO criteria disease status assessment Concurrent administration tumor therapy pregnant breast feed serious concomitant disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>